2023 World Conference on Lung Cancer (Posters)-P1.26. A Real World Study of Perioperative Outcomes after Minimally Invasive Segmentectomy versus Lobectomy for Early-Stage Lung Cancer

P1.26. A Real World Study of Perioperative Outcomes after Minimally Invasive Segmentectomy versus Lobectomy for Early-Stage Lung Cancer - PDF(Slides)

Back to course

Pdf Summary

This study conducted by Yang Chen, Yiyang Wang, and Wentao Fang from Shanghai Chest Hospital in China aimed to compare the perioperative outcomes of minimally invasive segmentectomy and lobectomy for early-stage lung cancer. The study included patients with stage IA non-small cell lung cancer (NSCLC) who underwent these procedures in seven Chinese and Italian hospitals between 2014 and 2020. <br /><br />The results showed that among the well-balanced group of 721 pairs of IA NSCLC patients, segmentectomy was associated with shorter length of chest tube and hospital stays compared to lobectomy. However, segmentectomy had a longer operative time. There were no differences in postoperative complications or cardio-pulmonary complications between the two procedures. <br /><br />In the subgroup analysis of high-risk patients, there was no significant difference in perioperative outcomes between segmentectomy and lobectomy. However, the segmentectomy 1/2 lobe group demonstrated a 77.5% probability of reducing morbidity grade 3 compared to lobectomy.<br /><br />Based on these findings, the study concludes that minimally invasive segmentectomy is a safe and feasible procedure for patients with stage IA lung cancer. For high-risk patients, segmentectomy 1/2 lobe may help reduce perioperative risks compared to lobectomy.

Asset Subtitle

Yang Chen

Meta Tag

Speaker Yang Chen

Topic Early-Stage NSCLC: More Minimally Invasive Approaches

Keywords

minimally invasive segmentectomy

lobectomy

perioperative outcomes

early-stage lung cancer

stage IA non-small cell lung cancer

chest tube

hospital stays

operative time

postoperative complications

high-risk patients